Literature DB >> 22040641

[Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].

N Rodríguez-González1, C Pérez-Rico, R López-Para Giménez, J Arévalo-Serrano, B Del Amo García, L Calzada Domingo, L Flores Ruiz, R Blanco.   

Abstract

OBJECTIVE: To evaluate the orbital structures and to establish correlations with disease activity and severity in patients with Graves' hyperthyroidism and orbitopathy (GO) using short-tau inversion-recovery (STIR) sequence magnetic resonance imaging (MRI).
METHODS: Observational, cross-sectional, case-control study. Twenty-eight patients with euthyroid status after treatment and GO (GO group) and 15 control subjects (control group) were included. Patients underwent a complete ophthalmologic examination and were then assessed according to the EUGOGO (European Group on Graves' Orbitopathy) recommendations. Muscle cross-sectional areas, orbital tissue volumes and the signal intensity ratio (SIR) from the most inflamed extraocular muscle were calculated using a STIR-T2 weighted sequence MRI. Correlations between clinical and MRI measurements were analyzed.
RESULTS: Enlargements in the cross-sectional areas and volumes were significant for most EOMs (P<.001), but not for the lateral rectus muscle cross-sectional area. A significant difference in SIR values between patients with GO and control subjects (P<.001) was found. No significant correlations were found between muscle cross-sectional areas, orbital tissue volumes, SIR values and the clinical activity parameters.
CONCLUSIONS: Given the small sample size of our study, with the obvious need for larger clinical trials, we were unable to demonstrate that the STIR sequences in MRI are a sensitive tool in assessing patients with longstanding GO in order to detect inflammatory changes and activity follow-up, possibly because it is in inactive phase. Meanwhile, it is still necessary to continue performing a thorough clinical evaluation in the therapeutic management of GO. Copyright Â
© 2010 Sociedad Española de Oftalmología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22040641     DOI: 10.1016/j.oftal.2011.06.010

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  9 in total

1.  Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy.

Authors:  Ji Sung Han; Hyung Suk Seo; Young Hen Lee; Hwa Lee; Sang-Il Suh; Eun-Kee Jeong; Nabraj Sapkota; Ki Joon Kim
Journal:  Neuroradiology       Date:  2016-11-14       Impact factor: 2.804

2.  Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues.

Authors:  Hao Hu; Xiao-Quan Xu; Lu Chen; Wen Chen; Qian Wu; Huan-Huan Chen; Hui Zhu; Hai-Bin Shi; Fei-Yun Wu
Journal:  Endocrine       Date:  2020-06-05       Impact factor: 3.633

3.  Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease.

Authors:  R Kilicarslan; A Alkan; M M Ilhan; H Yetis; A Aralasmak; E Tasan
Journal:  Br J Radiol       Date:  2014-12-19       Impact factor: 3.039

4.  Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Katsutaro Morino; Satoshi Ugi; Yoshihiko Nishio; Hiroshi Maegawa; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2014-12-03       Impact factor: 2.447

5.  Clinical and Radiological Findings in Patients with Newly Diagnosed Graves' Ophthalmopathy.

Authors:  Yakup Cevik; Hande Taylan Sekeroglu; Burce Ozgen; Kadriye Erkan Turan; Ali Sefik Sanac
Journal:  Int J Endocrinol       Date:  2021-04-30       Impact factor: 3.257

6.  Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves' orbitopathy and analysis on who requires additional therapy.

Authors:  Theodora Tsirouki; Alexandra Bargiota; Stelios Tigas; Agathi Vasileiou; Eftichia Kapsalaki; Zoe Giotaki; Ioannis Asproudis; Agathokles Tsatsoulis; Georgios Koukoulis; Evangelia E Tsironi
Journal:  Clin Ophthalmol       Date:  2016-11-17

Review 7.  Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.

Authors:  Allan C Pieroni Gonçalves; Eloísa M M S Gebrim; Mário L R Monteiro
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

8.  Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Masahito Ohji
Journal:  Clin Ophthalmol       Date:  2016-04-20

9.  Thyroid-Associated Orbitopathy: Evaluating Microstructural Changes of Extraocular Muscles and Optic Nerves Using Readout-Segmented Echo-Planar Imaging-Based Diffusion Tensor Imaging.

Authors:  Huan Huan Chen; Hao Hu; Wen Chen; Dai Cui; Xiao Quan Xu; Fei Yun Wu; Tao Yang
Journal:  Korean J Radiol       Date:  2020-03       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.